The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of sitravatinib combined with PD-1 blockade on cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma.
 
Ashten Omstead
No Relationships to Disclose
 
Ping Zheng
No Relationships to Disclose
 
Ryan Sweeny
No Relationships to Disclose
 
Anastasia Gorbunova
No Relationships to Disclose
 
Arul Goel
No Relationships to Disclose
 
Patrick Wagner
No Relationships to Disclose
 
Ronan Joseph Kelly
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sanyo; Eisai; EMD Serono; Grail; Ipsen; Lilly; McKesson; Medscape; Merck; Novartis; Novocure; Onc Live; Peerview; Philips Healthcare; Pieris Pharmaceuticals; STERIS; Takeda; Toray Industries
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst)
Expert Testimony - Merck
 
Blair A Jobe
No Relationships to Disclose
 
Ali Hussainy Zaidi
No Relationships to Disclose